. 1958 Dec;18(6):521-30.

The biotransformation of benzidine (4, 4'-diaminobiphenyl), and industrial carcinogen, in the dog. I

L J SCIARINI et al. AMA Arch Ind Health. 1958 Dec.

. 1958 Dec;18(6):521-30.

No abstract available

Similar articles

Oxidative activation of benzidine and its derivatives by peroxidases.
Josephy PD. Josephy PD. Environ Health Perspect. 1985 Dec;64:171-8. doi: 10.1289/ehp.8564171. Environ Health Perspect. 1985. PMID: 3007087 Free PMC article.
Carcinogen-DNA adduct formation as a predictor of metabolic activation pathways and reactive intermediates in benzidine carcinogenesis.
Kadlubar FF, Yamazoe Y, Lang NP, Chu DZ, Beland FA. Kadlubar FF, et al. Adv Exp Med Biol. 1986;197:537-49. doi: 10.1007/978-1-4684-5134-4_51. Adv Exp Med Biol. 1986. PMID: 3766280 No abstract available.
Biotransformation of the benzidines. III. Studies on diorthotolidine, dianisidine, and dichloro-benzidine: 3, 3' disubstituted congeners of benzidine (4, 4'-diaminobiphenyl).
SCIARINI LJ, MEIGS JW. SCIARINI LJ, et al. Arch Environ Health. 1961 May;2:584-8. doi: 10.1080/00039896.1961.10662906. Arch Environ Health. 1961. PMID: 13749284 No abstract available.
Activation of 3,3'-dichlorobenzidine: enzymic basis and toxicological consequences.
Iba MM. Iba MM. Drug Metab Rev. 1989-1990;21(3):377-400. doi: 10.3109/03602538909030303. Drug Metab Rev. 1989. PMID: 2701169 Review. No abstract available.
Benzidine revisited: a review of the literature and problems associated with the use of benzidine and its congeners.
Haley TJ. Haley TJ. Clin Toxicol. 1975;8(1):13-42. doi: 10.3109/15563657508988044. Clin Toxicol. 1975. PMID: 805682 Review. No abstract available.

Induction of sister chromatid exchanges by benzidine in rat and human hepatoma cell lines and inhibition by indomethacin.
Grady MK, Jacobson-Kram D, Dearfield KL, Williams JR. Grady MK, et al. Cell Biol Toxicol. 1986 Jun;2(2):223-30. doi: 10.1007/BF00122691. Cell Biol Toxicol. 1986. PMID: 3267448